Current Problems in Cancer
Volume 30, Issue 6 , Pages 272-282 , November 2006

Choosing the “Correct” Assessment Tool

  • Denise J. Smith, BS
    • ,
  • Jef Huntington, BS
    • ,
  • Jeff A. Sloan

      Affiliations

    • Corresponding Author InformationAddress correspondence to Dr. Jeff A. Sloan, Mayo Clinic, Section of Biostatistics, Department of Health Science Research, 200 First St. S.W., Rochester, MN 55905, USA.

References 

  1. Sloan JA, Aaronson N, Cappelleri JC, Fairclough DL, Varricchio C Clinical Significance Consensus Meeting Group. Assessing the clinical significance of single items relative to summated scores. Mayo Clinic Proc. 2002;77:479–487
  2. McHorney CA. Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med. 1997;127:743–750
  3. National Cancer Institute. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 2003;December 12, Available from: http://ctep.cancer.gov/forms/CTCAEv3.pdf. Accessed February 27, 2006.
  4. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer. 1984;53:2002–2007
  5. Schaafsma J, Osoba D. The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res. 1994;3:413–424
  6. Ware JE, Kosinski M, Gandek B, Aaronson NK, Apolone G, Bech P, et al. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project (International Quality of Life Assessment). J Clin Epidemiol. 1998;51:1159–1165
  7. Cella DF. Quality of life outcomes: measurement and validation. Oncology. 1996;10:233–246
  8. Eton DT, Koffler K, Cella D, Eisenstein A, Astin JA, Pelletier KR, et al. Developing a self-report outcome measure for complementary and alternative medicine. Explore (NY). 2005;1(3):177–185
  9. Ware JE. Standards for validating health measures: definition and content. J Chron Dis. 1987;40:473–480
  10. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: the example of health-related quality of life: a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Info J. 2002;36:209–238
  11. Sloan JA, Dueck A. Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat. 2004;14:73–96
  12. Nunnally JC, Bernstein IH. Psychometric Theory. (3rd ed).. New York, NY: McGraw-Hill; 1994;
  13. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, et al. Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis. 1981;34:585–597
  14. Sutherland HJ, Lockwood GA, Cunningham AJ. A simple, rapid method for assessing psychological distress in cancer patients: evidence of validity for linear analog scales. J Psychosoc Oncol. 1989;7:31–43
  15. Curran SL, Andrykowski MA, Studts JL. Short form of the profile of mood states (POMS-SF): psychometric information. Psychol Assess. 1995;7:80–83
  16. Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW. Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale. Qual Life Res. 2003;12:485–501
  17. Osoba D. A taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results. Med Care. 2002;40:III31–III38
  18. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, et al. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005;104:176–182
  19. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978;1:373–378
  20. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994;23:129–138
  21. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain. 1975;1:277–299
  22. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients use of the Brief Fatigue Inventory. Cancer. 1999;85:1186–1196
  23. Strohschein FJ, Kelly CG, Clarke AG, Westbury CF, Shuaib A, Chan KM. Applicability, validity, and reliability of the Piper Fatigue Scale in postpolio patients. Am J Phys Med & Rehab. 2003;82:122–129
  24. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74
  25. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70
  26. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–169
  27. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579
  28. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216

PII: S0147-0272(06)00056-0

doi: 10.1016/j.currproblcancer.2006.08.005

Current Problems in Cancer
Volume 30, Issue 6 , Pages 272-282 , November 2006

Article Tools

* Image Usage & Resolution